CarePath WeightFREE forever

Soft medical · wellness companion

Trust Library

Curated official guidelines & evidence — no invented URLs.

WHO — Obesity and overweight fact sheet

Epidemiology, adult BMI cutoffs, prevention framing.

definitionsbmiprevention

WHO — Health topic: Obesity

High-level disease framing and acceleration-plan context.

definitionsframing

WHO 2025 — GLP-1 therapies for obesity in adults

Conditional long-term use of incretin therapies; lifestyle adjunct; equity caveats; not a dosing cookbook.

Locale note: Guideline mirrors: MAGIC/PAHO. Confirm with clinician + local label.

pharmacotherapyglp1

WHO — Integrated management of obesity in children

Pediatric integrated care: diet, activity, sleep, behaviour, multimodal.

pediatricfamily

CDC — Obesity hub

Population prevention, BMI in clinics, community strategies.

preventionpublic-health

CDC — Obesity strategies: what can be done

Evidence-based community food/activity environments and referral programs.

prevention

CDC — Adult BMI tools

BMI calculation education for lay users.

bmi

NIDDK — Prescription medications for overweight & obesity

FDA-approved AOMs at high level — not a dose recipe. Continue if benefit / stop if not.

pharmacotherapy

NIDDK — Talking with patients about weight

Lifestyle intensity, meds, surgery candidacy themes for shared decisions.

shared-decision

NICE NG246 — Overweight and obesity management

Full UK pathway: identification, behaviour, diet, PA, medicines, surgery, CYP.

pathwayclinical

NICE NG246 — Medicines and surgery chapter

Adjunct medicines + diet/activity; specialist service framing.

pharmacotherapysurgery

AACE 2025 — Obesity / ABCD algorithm

Complication-centric adult care, staging, preferred medication hierarchies.

pharmacotherapycomorbidity

ASMBS/IFSO 2022 — Indications for metabolic & bariatric surgery

Modern candidacy: BMI ≥35; BMI 30–34.9 with T2DM; lower Asian thresholds.

surgery

EASO — European guidelines for obesity management in adults

Adult stepwise care; lifestyle first; pharma/surgery thresholds.

pathwayeu

EASO 2025 — Pharmacological treatment framework

Complication-centric drug selection among EU-available AOMs.

pharmacotherapyeu

Israel MoH — Metabolic & bariatric surgery circular (MR04_2024)

Israeli eligibility/process: MDT committee, BMI/comorbidity bands, follow-up.

Locale note: Prefer primary MoH PDF when available; this is the public circular index summary.

surgeryisraelhe

IMA — Prevention & treatment of obesity (clinical instruction)

Multidisciplinary lifestyle core; meds/surgery for selected cases.

israelhepathway

Israel MoH — Efshari Bari (healthy lifestyle)

Population prevention, diet & activity messaging (not a full obesity CPG).

preventionisraelhe

Saudi CPG — Overweight & obesity in adults (2016)

Lifestyle, counselling, PA; note year — 2024 update literature exists.

gulfarpathway

UAE MoHAP — Clinical Guideline for Weight Management

Adult prevention + management; multidisciplinary lifestyle; meds/surgery BMI themes.

gulfarpathway

WHO 2020 — Physical activity and sedentary behaviour

≥150–300 min/week moderate aerobic + strength ≥2 days/week.

exercise

Cochrane — Exercise for overweight or obesity

Exercise alone → modest weight loss; clear cardiometabolic benefits.

exerciseevidence

Cochrane — Surgery for obesity in adults

Surgery > nonsurgical for weight & diabetes outcomes; harms/uncertainty noted.

surgeryevidence

VA/DoD 2025 — Management of Adult Overweight and Obesity

Current US multi-agency treatment CPG including pharma hierarchy + surgery.

pathwaypharmacotherapysurgery